Enavate Sciences GP, LLC

Q4 2024 13F Holdings

  • Location
    menlo park, CA
  • Num holdings

    5

  • Value ($000)

    $139,237

  • Date Filed
    02/14/2025
  • Form type
    13F-HR
  • CIK
    0001953107
  • All SEC filings
  • Note
    Holdings aggregated across “other managers” listed in original SEC filing, see here for detailed holdings broken out by other managers
Compare Q4 2024 to
Issuer Name
Class
CUSIP
VALUE
%
Shares
Principal
Option Type
---

UPSTREAM BIO INC

COM
91678A107
$40.44M
29 %

2,459,703

IMNM
IMNM

IMMUNOME INC

COM
45257U108
$36.94M
27 %

3,478,261

---

ZENAS BIOPHARMA INC

COM
98937L105
$30.81M
22 %

3,761,359

---

CAMP4 THERAPEUTICS CORP

COM
13463J101
$19.76M
14 %

3,785,802

CMPX
CMPX

COMPASS THERAPEUTICS INC

COM
20454B104
$11.29M
8 %

7,788,150

Rows Per Page
10
  • 10
  • 50
  • 100
1 - 5 of 5